Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Carcinoma”

2,175 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,175 results

Not applicableEnded earlyNCT02494635
What this trial is testing

Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer

Who this might be right for
Bladder Papillary Urothelial CarcinomaStage 0a Bladder Urothelial CarcinomaStage 0is Bladder Urothelial Carcinoma+5 more
University of Southern California 4
Not applicableUnknownNCT02992990
What this trial is testing

Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade

Who this might be right for
Bladder Cancer
Baylor College of Medicine 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03022825
What this trial is testing

QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
ImmunityBio, Inc. 190
Testing effectiveness (Phase 2)UnknownNCT04060459
What this trial is testing

Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Third Military Medical University 50
Early research (Phase 1)Study completedNCT00199849
What this trial is testing

NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine

Who this might be right for
Prostate CancerBladder CancerNon-small Cell Lung Cancer+2 more
Ludwig Institute for Cancer Research 18
Testing effectiveness (Phase 2)Study completedNCT04383743
What this trial is testing

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Who this might be right for
Stage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8Muscle Invasive Bladder Carcinoma
University of Washington 17
Testing effectiveness (Phase 2)WithdrawnNCT03832673
What this trial is testing

Pembrolizumab-Epacadostat Combination to Treat Muscle-invasive Bladder UrotheLIAl canceR: PECULIAR Study

Who this might be right for
Muscle-invasive Bladder Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Not applicableStudy completedNCT03390127
What this trial is testing

Effect of PEEP on Arterial Oxygen Partial Pressure in Elderly Patients With Lithotomy Position Using LMA Supreme™

Who this might be right for
Urinary Bladder NeoplasmsProstatic Neoplasms
Asan Medical Center 68
Not applicableStudy completedNCT00829920
What this trial is testing

The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced Disease

Who this might be right for
Bladder Cancer
University of Colorado, Denver 44
Not applicableLooking for participantsNCT00001823
What this trial is testing

Evaluation for NCI Surgery Branch Clinical Research Protocols

Who this might be right for
Synovial Cell CancerMelanomaColorectal Cancer+2 more
National Cancer Institute (NCI) 7,000
Not applicableStudy completedNCT04256161
What this trial is testing

Measurements of Sexual Steroids' Concentrations in Prostatic Tissue

Who this might be right for
Bladder Cancer
Hopital Foch 24
Testing effectiveness (Phase 2)Study completedNCT02365766
What this trial is testing

Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects

Who this might be right for
Urothelial CarcinomaBladder Cancer
Jason R. Brown 83
Not applicableStudy completedNCT04964895
What this trial is testing

Sexual Quality of Patients After Bladder Cancer Cystectomy

Who this might be right for
Sexual Dysfunction
University Hospital, Toulouse 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06880757
What this trial is testing

177Lu-FAP-2286 Treatment in Urethelial Neoplasms: Utility and Safety as a Novel Treatment.

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable
Ankara University 10
Not applicableStudy completedNCT05939856
What this trial is testing

Lymph Node Dissection Before or After Cystectomy

Who this might be right for
Bladder Cancer
Jagiellonian University 50
Testing effectiveness (Phase 2)UnknownNCT05957757
What this trial is testing

RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression

Who this might be right for
Non-Muscle Invasive Bladder CancerHER2
RenJi Hospital 20
Not applicableUnknownNCT05626101
What this trial is testing

Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study

Who this might be right for
Non-muscle-invasive Bladder Cancer
Al-Azhar University 280
Not applicableLooking for participantsNCT04970472
What this trial is testing

Bio Clinical Collection of Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaBladder Cancer
University Hospital, Toulouse 1,000
Testing effectiveness (Phase 2)Study completedNCT00023842
What this trial is testing

BCG With or Without Mitomycin in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 97
Early research (Phase 1)Study completedNCT02300610
What this trial is testing

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

Who this might be right for
Bladder CancerCarcinoma, Transitional CellRenal Pelvis Cancer+2 more
H. Lee Moffitt Cancer Center and Research Institute 10
Load More Results